Who are Usual dose treatment of Tandospirone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Trintellix, Buspirone and Grapefruit Juice, Aripiprazole tablet, Aripiprazole; Quetiapine, buspirone+alprazolam, Abilify Maintena.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/usual-dose-treatment-of-tandospirone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Usual dose treatment of Tandospirone — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Usual dose treatment of Tandospirone (Usual dose treatment of Tandospirone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: 5-HT1A receptor agonist. Area: Psychiatry/Neurology.

marketed 5-HT1A receptor agonist 5-HT1A receptor Psychiatry/Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Usual dose treatment of Tandospirone (Usual dose treatment of Tandospirone) — Sumitomo Pharma (Suzhou) Co., Ltd.. Tandospirone is a serotonin 1A (5-HT1A) receptor agonist that enhances serotonergic neurotransmission in the central nervous system.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Usual dose treatment of Tandospirone TARGET	Usual dose treatment of Tandospirone	Sumitomo Pharma (Suzhou) Co., Ltd.	marketed	5-HT1A receptor agonist	5-HT1A receptor
Trintellix	vortioxetine	Takeda	marketed	Serotonin modulator and stimulator (SMS); SSRI-like agent	Serotonin transporter (SERT); 5-HT3 receptor; 5-HT1A receptor	2013-01-01
Buspirone and Grapefruit Juice	Buspirone and Grapefruit Juice	North Dakota State University	marketed	Serotonin 5-HT1A receptor partial agonist (buspirone component)	5-HT1A receptor (buspirone); CYP3A4 enzyme (grapefruit juice inhibition)
Aripiprazole tablet	Aripiprazole tablet	All India Institute of Medical Sciences, Bhubaneswar	marketed	Atypical antipsychotic	Dopamine D2 receptor (partial agonist); Serotonin 5-HT1A receptor (partial agonist); Serotonin 5-HT2A receptor (antagonist)
Aripiprazole; Quetiapine	Aripiprazole; Quetiapine	Taichung Veterans General Hospital	marketed	Atypical antipsychotic combination	Dopamine D2 receptor; Serotonin 5-HT2A receptor; Serotonin 5-HT1A receptor
buspirone+alprazolam	buspirone+alprazolam	Seoul National University Hospital	marketed	Anxiolytic combination (azapirone + benzodiazepine)	5-HT1A receptor (buspirone); GABA-A receptor (alprazolam)
Abilify Maintena	Abilify Maintena	Gazda, Thomas D., M.D., PC	marketed	Atypical antipsychotic	Dopamine D2 receptor (partial agonist); serotonin 5-HT1A receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (5-HT1A receptor agonist class)

Par Pharmaceutical, Inc. · 1 drug in this class
Sumitomo Pharma (Suzhou) Co., Ltd. · 1 drug in this class
Supernus Pharmaceuticals, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Usual dose treatment of Tandospirone — Competitive Intelligence Brief. https://druglandscape.com/ci/usual-dose-treatment-of-tandospirone. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab